Toll-like receptor 2 mediates invasion via activating NF-κB in MDA-MB-231 breast cancer cells

Biochemical and Biophysical Research Communications

Volumn 379, Issue 4, 2009, Pages 1027-1032

  Xie, Wenjie ^a   Wang, Yongsheng ^a   Huang, Yafang ^a   Yang, Hongzhen ^a   Wang, Jiaping ^a   Hu, Zhuowei ^a  

^a INSTITUTE OF MATERIA MEDICA   (China)

Author keywords

Cell invasiveness; MCF 7 cells; MDA MB 231 cells; NF B; Toll like receptor 2

Indexed keywords

GELATINASE B; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; TOLL LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA ACTIVATED KINASE 1; VASCULOTROPIN;

ARTICLE; BREAST CANCER; CANCER CELL CULTURE; CELL INVASION; CELL STRAIN MCF 7; CONTROLLED STUDY; CYTOKINE RELEASE; ENZYME ACTIVITY; ENZYME RELEASE; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION;

BREAST NEOPLASMS; CELL LINE, TUMOR; HUMANS; INTERLEUKIN-6; MATRIX METALLOPROTEINASE 9; NEOPLASM INVASIVENESS; NF-KAPPA B; TOLL-LIKE RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 58949103657     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.01.009     Document Type: Article

References (25)

1. Pantel K., and Brakenhoff R.H. Dissecting the metastatic cascade. Nat. Rev. Cancer 4 (2004) 448-456
2. Zuo Y., Shields S.K., and Chakraborty C. Enhanced intrinsic migration of aggressive breast cancer cells by inhibition of Rac1 GTPase. Biochem. Biophys. Res. Commun. 15 (2006) 361-367
3. Takeda K., Kaisho T., and Akira S. Toll-like receptors. Annu. Rev. Immunol. 21 (2003) 335-376
4. Pevsner-Fischer M., Morad V., Cohen-Sfady M., Rousso-Noori L., Zanin-Zhorov A., Cohen S., Cohen I.R., and Zipori D. Toll-like receptors and their ligands control mesenchymal stem cell functions. Blood 109 (2007) 1422-1432
5. Song M.J., Kim K.H., Yoon J.M., and Kim J.B. Activation of Toll-like receptor 4 is associated with insulin resistance in adipocytes. Biochem. Biophys. Res. Commun. 4 (2006) 739-745
6. Huang B., Zhao J., Li H., He K.L., Chen Y., Mayer L., Unkeless J.C., and Xiong H. Toll-like receptors on tumor cells facilitate evasion of immune surveillance. Cancer Res. 65 (2005) 5009-5014
7. Huang B., Zhao J., Shen S., Li H., He K.L., Shen G.X., Mayer L., Unkeless J., Li D., Yuan Y., Zhang G.M., Xiong H., and Feng Z.H. Listeria monocytogenes promotes tumor growth via tumor cell Toll-like receptor 2 signaling. Cancer Res. 67 (2007) 4346-4352
8. Huber M.A., Azoitei N., Baumann B., Grunert S., Sommer A., Pehamberger H., Kraut N., Beug H., and Wirth T. NF-κB is essential for epithelial-mesenchymal transition and metastasis in a model of breast cancer progression. J. Clin. Invest. 114 (2004) 569-581
9. Park B.K., Zhang H., Zeng Q., Dai J., Keller E.T., Giordano T., Gu K., Shah V., Pei L., Zarbo R.J., McCauley L., Shi S., Chen S., and Wang C.Y. NF-κB in breast cancer cells promotes osteolytic bone metastasis by inducing osteoclastogenesis via GM-CSF. Nat. Med. 13 (2007) 62-69
10. Schafer Z.T., and Brugge J.S. IL-6 involvement in epithelial cancers. J. Clin. Invest. 117 (2007) 3660-3663
11. Sansone P., Storci G., Tavolari S., Guarnieri T., Giovannini C., Taffurelli M., Ceccarelli C., Santini D., Paterini P., Marcu K.B., Chieco P., and Bonafe M. IL-6 triggers malignant features in mammospheres from human ductal breast carcinoma and normal mammary gland. J. Clin. Invest. 117 (2007) 3988-4002
12. Hooper A.T., Akiri G., Jin D., Shmelkov S.V., Chuang E., Shin S.J., Wu Y., Hicklin D.J., Rafii S., and Vahdat L.T. VEGF receptor expression on reactive breast cancer stroma: paving the way for tumor invasion. J. Clin. Oncol. 23 (2005) 9642-9650
13. Kokkinopoulos I., Jordan W.J., and Ritter M.A. Toll-like receptor mRNA expression patterns in human dendritic cells and monocytes. Mol. Immunol. 42 (2005) 957-968
14. Connolly L., and Maxwell P. Image analysis of transwell assays in the assessment of invasion by malignant cell lines. Br. J. Biomed. Sci. 59 (2002) 11-14
15. Krutzik P.O., and Nolan G.P. Intracellular phospho-protein staining techniques for flow cytometry: monitoring single cell signaling events. Cytometry 55 (2003) 61-70
16. Karin M., Cao Y., Greten F.R., and Li Z.W. NF-κB in cancer: from innocent bystander to major culprit. Nat. Rev. Cancer 2 (2002) 301-310
17. Kim S.H., Cho N.H., Kim K., Lee J.S., Koo B.S., Kim J.H., Chang J.H., and Choi E.C. Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J. Surg. Oncol. 93 (2006) 330-337
18. Yao E.S., Zhang H., Chen Y.-Y., Lee B., Chew K., Moore D., and Park C. Increased β1 integrin is associated with decreased survival in invasive breast cancer. Cancer Res. 67 (2007) 659-664
19. Mauro L., Catalano S., Bossi G., Pellegrino M., Barone I., Morales S., Giordano C., Bartella V., Casaburi I., and Ando S. Evidences that leptin up-regulates E-cadherin expression in breast cancer: effects on tumor growth and progression. Cancer Res. 67 (2007) 3412-3421
20. Bianchi M.E. DAMPs, PAMPs and alarmins: all we need to know about danger. J. Leukoc. Biol. 81 (2007) 1-5
21. Coussens L.M., and Werb Z. Inflammation and cancer. Nature 420 (2002) 860-867
22. Sethi G., Ahn K.S., Sung B., and Aggarwal B.B. Pinitol targets nuclear factor-κB activation pathway leading to inhibition of gene products associated with proliferation, apoptosis, invasion, and angiogenesis. Mol. Cancer Ther. 7 (2008) 1604-1614
23. Buck M.B., and Knabbe C. TGF-β signaling in breast cancer. Ann. NY Acad. Sci. 1089 (2006) 119-126
24. Sung B., Pandey M.K., Nakajima Y., Nishida H., Konishi T., Chaturvedi M.M., and Aggarwal B.B. Identification of a novel blocker of IkBa kinase activation that enhances apoptosis and inhibits proliferation and invasion by suppressing nuclear factor-κB. Mol. Cancer Ther. 7 (2008) 191-201
25. Ferrara A.R. Inflammatory breast cancer: challenges and developments. Radiol. Technol. 80 (2008) 49-60